B-Cell Non-Hodgkin Lymphoma Clinical Trials in Columbus, Ohio

3 studies are recruiting for b-cell non-hodgkin lymphoma in Columbus, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

    This clinical trial compares the effectiveness of geriatric assessment (GA) guided interventions to accelerate functional recovery after chimeric antigen receptor T-cell (CAR-T) therapy compared to standard of care (SOC) in patients 60 years and older with B-cell non-Hodgkin lymphoma (NHL) or multi…

    Stage
    Phase 2
    Ages
    60 and older
    Site
    Ohio State University Medical Center Dept. of Internal Medicine, Division of Hematology, Columbus, Ohio
    Locations
    4 in total
    Run by
    City of Hope Medical Center

    See if you can join NCT06052826 on ClinicalTrials.gov

  2. Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

    This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of surovatamig (AZD0486) monotherapy in adult participants with relapsed/refractory B-cell non-Hodgkin lymphoma (NHL) who have received at least two prior lines of therapies. The study has 2 Mod…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Research Site, Columbus, Ohio
    Locations
    94 in total
    Run by
    AstraZeneca

    See if you can join NCT06526793 on ClinicalTrials.gov

  3. A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

    The purpose of this study is to assess the safety and efficacy of surovatamig (formerly AZD0486) administered as monotherapy or in combination with other anticancer agents in participants with hematological malignancies

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Site, Columbus, Ohio
    Locations
    65 in total
    Run by
    AstraZeneca

    See if you can join NCT06564038 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.